Item 9 Labs Corp.
INLB · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,911 | -$3,407 | -$3,248 | -$18,484 |
| Dep. & Amort. | $433 | $443 | $443 | $512 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $860 | $459 | $1,053 | $465 |
| Change in WC | $3,983 | $2,027 | $834 | $3,944 |
| Other Non-Cash | $785 | $780 | -$417 | $1,694 |
| Operating Cash Flow | $150 | $303 | -$1,335 | -$238 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$63 | $1 | -$7 | -$1,409 |
| Net Acquisitions | $0 | $0 | $0 | -$3 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $21 |
| Investing Cash Flow | -$63 | $1 | -$7 | -$1,391 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$5 | -$225 | $1,278 | $1,242 |
| Stock Issued | $0 | $0 | $0 | $102 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$71 |
| Financing Cash Flow | -$5 | -$225 | $1,278 | $1,273 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $82 | $79 | -$64 | -$356 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $101 | $22 | $86 | $442 |
| End Cash | $183 | $101 | $22 | $86 |
| Free Cash Flow | $87 | $304 | -$1,341 | -$1,647 |